Skip to main content
. Author manuscript; available in PMC: 2008 Sep 15.
Published in final edited form as: Bioorg Med Chem. 2007 Jun 14;15(18):6193–6199. doi: 10.1016/j.bmc.2007.06.027

Table 2.

Data for GA-DZ conjugates against human tumor cell replication

Cmpd ED50 (μM) / Cell linea

KB KB-VIN A549 1A9 HCT-8 ZR-751 PC-3 DU-145 LN-Cap
5 1.6 2.5 2.0 0.9 1.7 2.8 1.4 3.1 0.6
29 0.8 2.8 2.2 0.8 1.9 3.0 1.1 3.6 2.8
30 0.9 1.9 2.8 1.6 2.0 1.9 2.8 9.9 6.5
31 6.2 >15 15.5 5.9 2.6 >15 7.4 >15 1.9
32 1.8 1.7 1.7 1.1 2.7 5.2 3.3 5.8 1.1
33 2.9 13.2 3.0 1.8 4.9 8.8 3.5 >15 6.8
34 3.0 8.7 3.2 1.3 2.2 2.7 1.6 2.7 4.4
35 NA NA >14 >14 >14 NA >14 >14 >14
36 9.9 NA >14 13.3 >14 >14 14.1 >14 14.1
37 NA NA NA >14 >14 NA 14.1 >14 14.1
38 >14 >14 NA NA >14 NA >14 13.0 >14
GA >21 >21 NA >21 19.5 NA >21 >21 >21
DZ NA NA >52 33.9 >52 >52 >52 >52 51.0
DOXb 0.1 4.97 0.18 0.02 1.20 0.04 0.26 0.15 0.04
a

Human epidermoid carcinoma of the lung (A549), ovarian (1A9), colon (HCT-8), breast (ZR-751), prostate (PC-3, DU-145, LN-Cap).

b

Doxorubicin